Literature DB >> 21916786

Treating pain in multiple sclerosis.

Andrea Truini1, Francesca Galeotti, Giorgio Cruccu.   

Abstract

INTRODUCTION: Multiple sclerosis (MS) is an inflammatory, demyelinating, central nervous system disease that frequently causes pain. AREAS COVERED: This article reviews the current literature and describes the therapeutic options for treating MS-related pain. The reader will be provided with current, evidence-based knowledge about the treatment of MS-related pain, and the review will take a practical approach to the various drugs for treating pain, including starting dose, titration and side effects. EXPERT OPINION: Only cannabinoids have been assessed in randomized, controlled trials. Because of the concern regarding the risk of abuse and psychiatric adverse events, published guidelines as well as expert recommendations suggest using them as second-line therapy only. Hence, current treatment should be based on the general principles for treating peripheral neuropathic pain, taking into account drug-induced adverse effects.

Entities:  

Mesh:

Year:  2011        PMID: 21916786     DOI: 10.1517/14656566.2011.607162

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  14 in total

1.  A sensitive and selective ELISA methodology quantifies a demyelination marker in experimental and clinical samples.

Authors:  Albert G Remacle; Jennifer Dolkas; Mila Angert; Swathi K Hullugundi; Andrei V Chernov; R Carter W Jones; Veronica I Shubayev; Alex Y Strongin
Journal:  J Immunol Methods       Date:  2018-02-08       Impact factor: 2.303

2.  Effects of topiramate on dysaesthetic pain in a patient with multiple sclerosis.

Authors:  Antonio Siniscalchi; Luca Gallelli; Giovambattista De Sarro
Journal:  Clin Drug Investig       Date:  2013-02       Impact factor: 2.859

3.  Mechanisms and pharmacology of neuropathic pain in multiple sclerosis.

Authors:  T Iannitti; B J Kerr; B K Taylor
Journal:  Curr Top Behav Neurosci       Date:  2014

Review 4.  A systematic review of pharmacological pain management in multiple sclerosis.

Authors:  Rachel Jawahar; Unsong Oh; Shibing Yang; Kate L Lapane
Journal:  Drugs       Date:  2013-10       Impact factor: 9.546

Review 5.  A mechanism-based classification of pain in multiple sclerosis.

Authors:  A Truini; P Barbanti; C Pozzilli; G Cruccu
Journal:  J Neurol       Date:  2012-07-04       Impact factor: 4.849

6.  Topical moringin-cream relieves neuropathic pain by suppression of inflammatory pathway and voltage-gated ion channels in murine model of multiple sclerosis.

Authors:  Sabrina Giacoppo; Renato Iori; Placido Bramanti; Emanuela Mazzon
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

7.  Psychiatric and physical comorbidities and pain in patients with multiple sclerosis.

Authors:  Rogier Scherder; Neeltje Kant; Evelien T Wolf; Bas Pijnenburg; Erik Ja Scherder
Journal:  J Pain Res       Date:  2018-02-13       Impact factor: 3.133

Review 8.  Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models.

Authors:  Nemat Khan; Maree T Smith
Journal:  Inflammopharmacology       Date:  2014-02       Impact factor: 4.473

9.  Effects of vaccination with altered Peptide ligand on chronic pain in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.

Authors:  David H Tian; Chamini J Perera; Vasso Apostolopoulos; Gila Moalem-Taylor
Journal:  Front Neurol       Date:  2013-10-29       Impact factor: 4.003

10.  Sex differences in a mouse model of multiple sclerosis: neuropathic pain behavior in females but not males and protection from neurological deficits during proestrus.

Authors:  Elizabeth J Rahn; Tommaso Iannitti; Renee R Donahue; Bradley K Taylor
Journal:  Biol Sex Differ       Date:  2014-02-28       Impact factor: 5.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.